Trump admin directs NIH to study ‘regret’ in transgender care


This recording was made using enhanced software.

Full story

  • The Trump administration has ordered the NIH to study “regret and detransition” among transgender individuals following gender-affirming care. A leaked memo used language some condemned and emphasized the urgency of the research, calling it a priority for President Donald Trump and HHS Secretary Robert Kennedy Jr.
  • Critics, including public health experts, said the terms are stigmatizing, while others argued that more data on detransition is needed.
  • The move follows recent cancellations of federal grants for transgender research.

Full Story

The Trump administration is directing the National Institutes of Health to study detransitioning among transgender individuals and any “regret” they may experience following gender-affirming care, according to an internal memo obtained by multiple outlets.

What did the memo say?

The memo was sent out two weeks ago by then-acting director Matthew Memoli. Several anonymous staffers shared the memo with NPR.

QR code for SAN app download

Download the SAN app today to stay up-to-date with Unbiased. Straight Facts™.

Point phone camera here

According to the publications, the memo instructed the NIH to study the effects of “social transition and/or chemical and surgical mutilation” in children who transition. The White House specifically requested research on “regret” and “detransition” in both children and adults who have undergone gender-affirming care.

The memo also stated the research is very important to President Donald Trump and Department of Health and Human Services Secretary Robert Kennedy Jr., who would like NIH funding announcements for the research within six months.

Critics criticize language used in memo

Harry Barbee, an assistant professor and social scientist at Johns Hopkins Bloomberg School of Public Health, reacted to the memo, telling NPR the terminology has no place in serious scientific or public health discourse.

“Chemical or surgical mutilation? These are deeply offensive terms,” he said. “The language has been historically used to stigmatize trans people. Even the phrase[s] ‘regret’ and ‘detransition’ can be weaponized.”

Supporters call for more research on detransition

On the other side, some argue studies on those who detransition are necessary because regret is a serious topic that needs more data.

“We are starting to see much greater numbers of young people who are seeing that they went down the wrong path for them and they’re now left with irreversible changes to their body and they no longer identify as transgender,” Evgenia Abbruzzese, the co-founder of the group Society for Evidence-Based Gender Medicine, told NPR.

Funding cuts to transgender research

In March, the Trump administration canceled multiple grants used for funding transgender research.

Harry Fogle (Video Editor) contributed to this report.
Tags: , ,

SAN provides
Unbiased. Straight Facts.

Don’t just take our word for it.


Certified balanced reporting

According to media bias experts at AllSides

AllSides Certified Balanced May 2025

Transparent and credible

Awarded a perfect reliability rating from NewsGuard

100/100

Welcome back to trustworthy journalism.

Find out more

SAN provides
Unbiased. Straight Facts.

Don’t just take our word for it.


Certified balanced reporting

According to media bias experts at AllSides

AllSides Certified Balanced May 2025

Transparent and credible

Awarded a perfect reliability rating from NewsGuard

100/100

Welcome back to trustworthy journalism.

Find out more

Bias comparison

  • Media outlets on the left frame the NIH study on transgender "regret" as a cynical attack, using scare quotes around "regret" to signal skepticism, and highlighting expert consensus that gender-affirming care is beneficial, even labeling opposition as "junk science."
  • Not enough unique coverage from media outlets in the center to provide a bias comparison.
  • Media outlets on the right emphasize the need to study "regret" following "so-called gender-transition treatments," suggesting potential harm and questioning the "transgender industry," while de-emphasizing expert support for gender-affirming care.

Media landscape

Click on bars to see headlines

28 total sources

Key points from the Left

  • The Trump administration has ordered the National Institutes of Health to investigate the effects of gender transition, including "regret" and "detransition," among children and adults, according to an internal memo from Acting NIH Director Mark Memoli.
  • Many researchers express concern over the study's direction, noting that regret after transition is low, as stated by Lindsey Dawson, who indicates regret rates are less than 1%.
  • Adrian Shanker claims, "What they're looking for is a political answer, not a scientific one."
  • Harry Barbee points out the terms "regret" and "detransition" are historically used to stigmatize trans individuals, emphasizing the need for research that respects their experiences.

Report an issue with this summary

Key points from the Right

  • The U.S. National Institutes of Health has been ordered to research regret among individuals who undergo gender-transition treatments, focusing on potential negative consequences of these procedures.
  • Theresa Farnan stated that many individuals regretting their transition often struggled with mental health issues prior to transitioning, advocating for awareness of alternative treatments.
  • Patrick Lappert emphasized the lack of information on the long-term effects of transition-related medications and surgeries, calling for further examination.
  • Dr. Roy Eappen described the NIH initiative as a significant step towards uncovering truths about the transgender industry that have been previously avoided, referencing European studies that led to changes in practices.

Report an issue with this summary

Powered by Ground News™

Daily Newsletter

Start your day with fact-based news

Start your day with fact-based news

Learn more about our emails. Unsubscribe anytime.

By entering your email, you agree to the Terms and Conditions and acknowledge the Privacy Policy.